Harnessing the power of structure‐based design: A new lease on life for cardiovascular drug development with apelin receptor modulators
Junxia Zhang, Erdan Dong, Yan Zhang, Yan Zhang · 2024
Read Harnessing the power of structure‐based design: A new lease on life for cardiovascular drug development with apelin receptor modulators by Junxia Zhang, Erdan Dong, Yan Zhang, Yan Zhang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11625507.txt.
Description
Junxia Zhang and co-authors argue that designing heart drugs from the shape of their target can revive a stalled field, in a 2024 review. Their test case is the apelin receptor, a switch on cell surfaces tied to blood pressure and heart function.
Receptors of this family are already the target of a large share of all drugs. New imaging methods now show their atomic shapes, letting chemists build molecules to fit. The review also covers biased drugs, which trigger only the helpful pathway of a receptor and dodge side effects. Heart disease kills more people than any other cause, yet few new heart drugs arrive compared with cancer drugs. The authors see structure-guided design as a way to close that gap.
Catalog record
| CREATOR | Junxia Zhang, Erdan Dong, Yan Zhang, Yan Zhang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 8 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |